Holter ECG Market by Product, Lead Type (12-Lead, 3-Lead, 6-Lead), End User

List of Tables

[196 Pages Report] The Holter ECG Market size was estimated at USD 446.99 million in 2023 and expected to reach USD 472.65 million in 2024, at a CAGR 6.08% to reach USD 676.03 million by 2030.

Global Holter ECG Market

KEY MARKET STATISTICS
Base Year [2023]	USD 446.99 million
Estimated Year [2024]	USD 472.65 million
Forecast Year [2030]	USD 676.03 million
CAGR (%)	6.08%

Holter ECG is a medical device that enables physicians to diagnose and monitor patients with heart rhythm disorders. These devices continuously record electrocardiogram (ECG) signals for 24 to 48 hours to detect abnormal heartbeats or arrhythmias requiring further investigation and treatment. Prevalence of cardiovascular diseases (CVDs), increasing aging population with increased risk of arrhythmias, technological advancements in remote cardiac monitoring, and growing awareness regarding early diagnosis and preventive healthcare measures are raising the need for efficient medical devices, including holter ECG, for appropriate diagnosis and treatment. However, the high cost of Holter ECG devices can be a financial barrier for small-scale healthcare facilities. The surge in the adoption of telemedicine services in remote patient monitoring has also created new opportunities for Holter ECG manufacturers to expand their product reach worldwide.

Regional Insights

The Holter ECG market is evolving in the Americas owing to the growing focus on cardiac health due to an aging population and increasing incidences of heart disease. Emphasis on improving cardiac care through investments in research and technology enhances diagnostic capabilities in the Americas. In the European Union, healthcare providers are adopting advanced technologies such as Holter ECG to improve patient outcomes by early detection of heart diseases. The EMEA region has experienced rapid growth in demand for advanced healthcare services with a focus on governments on healthcare infrastructure development and promoting medical tourism. There has been an increasing focus on creating awareness about preventive measures for cardiac conditions among the African population, raising the need for diagnostic solutions, including heart ECG. The APAC region is focusing on medical device research and development coupled with government schemes and programs emphasizing the importance of early diagnosis and intervention for cardiac conditions, which are expanding the deployment of Holter ECG in the healthcare facilities in the region. Besides, the technological advancements and integration of cutting-edge technologies are anticipated to enhance accuracy and precision, thereby accelerating the use of Holter ECG by end-users across the globe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Holter ECG Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Holter ECG Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Holter ECG Market, highlighting leading vendors and their innovative profiles. These include AlivCor Inc., Bardy Diagnostics, Inc., BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED, Cardiac Insight, Inc., custo med GmbH, EB Neuro S.p.A., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals Group Inc., Medtronic plc, Nasiff Associates, Inc., Nihon Kohden Corporation, Nissha Co. Ltd., OSI Systems, Inc., SCHILLER AG, Viatom Technology Co. Ltd., and VitalConnect.

Market Segmentation & Coverage

This research report categorizes the Holter ECG Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Software
- Wired Holter ECG Monitors
- Wireless Holter ECG Monitors
Lead Type
- 12-Lead
- 3-Lead
- 6-Lead
End User
- Ambulatory Surgical Centers
- Hospitals & Specialty Clinics
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Holter ECG Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Holter ECG Market?

3. What are the technology trends and regulatory frameworks in the Holter ECG Market?

4. What is the market share of the leading vendors in the Holter ECG Market?

5. Which modes and strategic moves are suitable for entering the Holter ECG Market?

Product Code: MRR-1730A405F98A

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Holter ECG Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of cardiovascular disorders worldwide
  - 5.1.1.2. Growing awareness for preventative healthcare and early diagnosis
  - 5.1.1.3. Increasing demand for ambulatory monitoring devices
- 5.1.2. Restraints
  - 5.1.2.1. High cost of Holter ECG devices
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in Holter ECG
  - 5.1.3.2. Emerging trend of remote healthcare monitoring
- 5.1.4. Challenges
  - 5.1.4.1. Technical and security issues associated with Holter ECGs
5.2. Market Segmentation Analysis
- 5.2.1. Product: Significant preference for wireless Holter ECG monitors due to convenience
- 5.2.2. Lead Type: Penetration of 12-lead Holter ECG for efficient cardiovascular diagnosis
- 5.2.3. End User: Proliferation of Holter ECGs in hospitals & specialty clinics
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Holter ECG Market, by Product

6.1. Introduction
6.2. Software
6.3. Wired Holter ECG Monitors
6.4. Wireless Holter ECG Monitors

7. Holter ECG Market, by Lead Type

7.1. Introduction
7.2. 12-Lead
7.3. 3-Lead
7.4. 6-Lead

8. Holter ECG Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals & Specialty Clinics

9. Americas Holter ECG Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Holter ECG Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Holter ECG Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. New Product Launch & Enhancement
  - 12.3.1.1. UltraLinQ to launch new cardiac monitoring product at Arab Health
  - 12.3.1.2. Xplore Lifestyle to launch CardiacSense, world's first medical grade watch to monitor the heart
- 12.3.2. Award, Recognition, & Expansion
  - 12.3.2.1. Three-lead Holter monitor for low-risk patients gains FDA 510(k) clearance

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. AlivCor Inc.
- 13.1.2. Bardy Diagnostics, Inc.
- 13.1.3. BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED
- 13.1.4. Cardiac Insight, Inc.
- 13.1.5. custo med GmbH
- 13.1.6. EB Neuro S.p.A.
- 13.1.7. Fukuda Denshi Co., Ltd.
- 13.1.8. GE HealthCare Technologies Inc.
- 13.1.9. Hill-Rom Holdings, Inc.
- 13.1.10. iRhythm Technologies, Inc.
- 13.1.11. Koninklijke Philips N.V.
- 13.1.12. LifeSignals Group Inc.
- 13.1.13. Medtronic plc
- 13.1.14. Nasiff Associates, Inc.
- 13.1.15. Nihon Kohden Corporation
- 13.1.16. Nissha Co. Ltd.
- 13.1.17. OSI Systems, Inc.
- 13.1.18. SCHILLER AG
- 13.1.19. Viatom Technology Co. Ltd.
- 13.1.20. VitalConnect
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing